CVS Health (NYSE: CVS) reported Q1 EPS of $1.48, $0.06 better than the analyst estimate of $1.42. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.79 billion.

GUIDANCE:

CVS Health sees FY2018 EPS of $6.87-$7.08, versus the consensus of $6.22.

CVS Health sees Q2 EPS of $1.59-$1.64, versus the consensus of $1.42.

For earnings history and earnings-related data on CVS Health (CVS) click here.